The first possibility is a toxic gain of function, a mechanism with precedents in several common neurological diseases (e.g., ALS caused by mutations in SOD1, Parkinson’s disease caused by mutations in SNCA) in which disease phenotypes are absent in KO animals but are faithfully recapitulated in animals expressing disease mutations. Here, SNCA is linked to amyotrophic lateral sclerosis.